Publications by authors named "Edward Lis"

Claim this Profile
U
Use of FDSS/μCell imaging platform for preclinical cardiac electrophysiology safety screening of compounds in human induced pluripotent stem cell-derived cardiomyocytes.
Haoyu Zeng, Maria I Roman, Edward Lis, Armando Lagrutta, Frederick Sannajust

J Pharmacol Toxicol Methods· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-parametric assessment of cardiomyocyte excitation-contraction coupling using impedance and field potential recording: A tool for cardiac safety assessment.
Xiaoyu Zhang, Liang Guo, Haoyu Zeng, Stephen L White, Michael Furniss, Edward Lis

J Pharmacol Toxicol Methods· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction between amiodarone and hepatitis-C virus nucleotide inhibitors in human induced pluripotent stem cell-derived cardiomyocytes and HEK-293 Cav1.2 over-expressing cells.
Armando Lagrutta, Haoyu Zeng, John Imredy, Bharathi Balasubramanian, Spencer Dech, Edward Lis

Toxicol Appl Pharmacol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice.
Karen M Smith, Susan E Browne, Srinivasan Jayaraman, Carina J Bleickardt, Lisa M Hodge, Edward Lis

Eur J Pharmacol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 3-substituted aminocyclopentanes as potent and orally bioavailable NR2B subtype-selective NMDA antagonists.
Mark E Layton, Michael J Kelly, Kevin J Rodzinak, Philip E Sanderson, Steven D Young, Edward V Lis

ACS Chem Neurosci· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling of a 6-hydroxydopamine model of Parkinson's disease.
Sang J Na, Anthony G DiLella, Edward V Lis, Keith Jones, David M Levine

Neurochem Res· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of 1-oxadecalins from anisole promoted by tungsten.
Edward C Lis, Rebecca J Salomon, Michal Sabat, William H Myers, W Dean Harman

J Am Chem Soc· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation and characterization of a human bradykinin receptor B1 transgenic rat as a pharmacodynamic model.
J Fred Hess, Richard W Ransom, Zhizhen Zeng, Raymond S L Chang, Patricia J Hey, Edward Lis

J Pharmacol Exp Ther· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Group III metabotropic glutamate receptor-mediated modulation of the striatopallidal synapse.
Ornella Valenti, Michael J Marino, Marion Wittmann, Edward Lis, Anthony G DiLella

J Neurosci· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzodiazepines as potent and selective bradykinin B1 antagonists.
Michael R Wood, June J Kim, Wei Han, Bruce D Dorsey, Carl F Homnick, Edward V Lis, Joan D Ellis

J Med Chem· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin.
Douglas J Pettibone, J Fred Hess, Patricia J Hey, Marlene A Jacobson, Michael Leviten, Edward V Lis, Melissa A Snyder

J Pharmacol Exp Ther· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis